Saudi Arabia Diabetes Care Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Saudi Arabia Diabetes Care Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

The Saudi Arabian diabetes care devices market is expected to register a CAGR greater than 4% over the forecast period (2022-2027).

In Riyadh, hospitalized COVID-19 patients had a significant frequency of diabetes mellitus. Even though people with diabetes have a higher mortality rate than people without the disease, other factors, including advanced age, congestive heart failure, smoking, use of -blockers, the presence of bilateral lung infiltrates, elevated creatinine, and severe vitamin D deficiency, seem to be more significant predictors of fatal outcomes. Patients who have immediate metabolic dysfunctions upon arrival, such as hyperglycemia, are more likely to need intensive care.

The Saudi Arabian Ministry of Health decided to impose the lockdown approach in March 2020 to control the spread of COVID-19. This lockdown had a major negative impact on children with Type-1 diabetes mellitus and has increased the occurrence of severe diabetes-related diseases, even in children with new-onset Type-1 diabetes mellitus. According to a study in Saudi Arabia, compliance with diabetes medication significantly increased during the lockdown, as the percentage of children who did not miss a dose of medications increased to 92.7%, compared to 70.7% before the lockdown.

Diabetes care devices are devices used to monitor glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. Continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations.

Key Market TrendsMonitoring Devices Segment Expected to Register Significant Growth

The Monitoring Devices Segment is expected to record a CAGR of over 11% during the forecast period. This growth may mainly be driven by the demand from the Type-1 diabetes population, which was more than 9 million by the end of 2027.

Monitoring devices include self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) devices. The SMBG devices segment held a major share in the Saudi Arabia diabetes devices market and generated a revenue of USD 91 million in 2021. The frequency of monitoring glucose levels depends on the type of diabetes. The awareness of self-monitoring of glucose levels has increased in Saudi Arabia, and the market for monitoring devices is expected to witness high growth, recording a CAGR of over 7% during the forecast period. Type-1 diabetic patients need to check their blood glucose levels at regular intervals to adjust the insulin dosing accordingly. The current CGM devices show a more detailed representation of blood glucose patterns and tendencies than what can be achieved by the conventional routine checking of glucose levels at set intervals. CGM device usage is a rising trend in Saudi Arabia because of technological advancements like the recently approved non-invasive glucose meter.

Thus, the above factors are expected to drive the growth of the market studied over the forecast period.

Saudi Arabia Recorded the Second-largest Diabetes Population in Middle-East and Africa in 2021

Diabetes is one of the largest health problems in Saudi Arabia. This country is ranked among the top 10 countries in the world with respect to the prevalence of diabetes. The diabetic population in Saudi Arabia increased from 3.83 million in 2016 to 5.95 million in 2021. This is expected to reach 9.23 million by 2027. Obesity, especially central obesity and increased visceral fat due to physical inactivity, and the consumption of high-calorie,high-fat, and high-sugar foods are the major contributing factors to diabetes. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and consuming fast food with little to no physical activity, is a significant contributor to diabetes in the working-age group.

Saudi Arabia is aiming to reduce the prevalence of diabetes by 10% over the next decade. Several initiatives, including taxing sugary drinks, fitness programs, and focusing on preventative care, are being taken by the government to stem this epidemic. The government’s focus on combating diabetes and the higher purchasing power of the people in the country may help the market for diabetes monitoring devices during the forecast period.

Competitive Landscape

The diabetes devices market in Saudi Arabia includes several established global players and local players. The CGM market in Saudi Arabia comprises only a few players that occupy major shares. However, in the SMBG market, the number of players is high and includes several local players.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Please note: The report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter's Five Force Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Monitoring Devices (Value and Volume, 2016 - 2027)
5.1.1 Self-Monitoring Blood Glucose Devices
5.1.1.1 Glucometer Devices
5.1.1.2 Blood Glucose Test Strips
5.1.1.3 Lancets
5.1.2 Continuous Glucose Monitoring Devices
5.1.2.1 Sensors
5.1.2.2 Durables (Receivers and Transmitters)
5.2 Management Devices (Value and Volume, 2016 - 2027)
5.2.1 Insulin Delivery Devices
5.2.1.1 Insulin Pump Devices
5.2.1.1.1 Insulin Pump Monitors
5.2.1.1.2 Insulin Pump Reserviors
5.2.1.1.3 Insulin Infusion Sets
5.2.1.2 Insulin Syringes
5.2.1.3 Insulin Disposable Pens
5.2.1.4 Insulin Cartridges in Reusable Pens
5.2.1.5 Jet Injectors
6 MARKET INDICATORS
6.1 Type - 1 Diabetes Population (2016 - 2027)
6.2 Type - 2 Diabetes Population (2016 - 2027)
7 COMPETITIVE LANDSCAPE
7.1 Company Profiles
7.1.1 Abbott Diabetes Care
7.1.2 F. Hoffmann-La Roche Ltd
7.1.3 Johnson & Johnson (LifeScan)
7.1.4 Arkray
7.1.5 Ascensia Diabetes Care
7.1.6 Sanofi
7.1.7 Dexcom Inc.
7.1.8 Medtronic
7.1.9 Novo Nordisk AS
7.1.10 Becton Dickinson
7.1.11 Eli Lilly
7.1.12 Ypsomed Holding AG
7.1.13 Terumo
7.2 Market Share Analysis
8 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings